Consolidation Paclitaxel is more Cost-Effective than Bevacizumab following Upfront Treatment of Advanced Epithelial Ovarian Cancer

由 Lesnock, Jamie L., Farris, Coreen, Krivak, Thomas C., Smith, Kenneth J., Markman, Maurie
出版 2011

Invasive endometrial adenocarcinoma and missed abortion: A case report

由 Gaulin, Nicole B., Harinath, Lakshmi, Liang, Sharon, Krivak, Thomas C., Miller, Eirwen M.
發表在 Gynecol Oncol Rep (2019)

Ovarian Cancer Screening and Early Detection in the General Population

由 Rauh-Hain, Jose A, Krivak, Thomas C, del Carmen, Marcela G, Olawaiye, Alexander B
出版 2011

A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemothe...

由 Krivak, Thomas C., Tian, Chunqiao, Rose, G. Scott, Armstrong, Deborah K., Maxwell, G. Larry
發表在 Gynecol Oncol (2009)

Proteomic Analysis of Ovarian Cancer Proximal Fluids: Validation of Elevated Peroxiredoxin 1 in Patient Peripheral Circulation

由 Hoskins, Ebony R., Hood, Brian L., Sun, Mai, Krivak, Thomas C., Edwards, Robert P., Conrads, Thomas P.
出版 2011

Dual-console robotic surgery: a new teaching paradigm

由 Smith, Ashlee L., Scott, Eirwen M., Krivak, Thomas C., Olawaiye, Alexander B., Chu, Tianjiao, Richard, Scott D.
出版 2012

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era

由 Berger, Jessica L, Smith, Ashlee, Zorn, Kristin K, Sukumvanich, Paniti, Olawaiye, Alexander B, Kelley, Joseph, Krivak, Thomas C
出版 2014

Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum

由 DeLoia, Julie A., Bhagwat, Nikhil R., Darcy, Kathleen M., Strange, Mary, Tian, Chunquio, Nuttall, Kevin, Krivak, Thomas C., Niedernhofer, Laura J.
出版 2012

Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insufficiency in female mice treated with alkylating chemotherapy

由 Skaznik-Wikiel, Malgorzata E., McGuire, Megan M., Sukhwani, Meena, Donohue, Julia, Chu, Tianjiao, Krivak, Thomas C., Rajkovic, Aleksandar, Orwig, Kyle E.
出版 2013

Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines

由 Sánchez-Vega, Francisco, Gotea, Valer, Petrykowska, Hanna M, Margolin, Gennady, Krivak, Thomas C, DeLoia, Julie A, Bell, Daphne W, Elnitski, Laura
出版 2013

Relationship Between ERCC1 Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Pa...

由 Krivak, Thomas C., Darcy, Kathleen M., Tian, Chunqiao, Armstrong, Deborah, Baysal, Bora E., Gallion, Holly, Ambrosone, Christine B., DeLoia, Julie A.
發表在 J Clin Oncol (2008)

Preoperative high dose rate brachytherapy for clinical stage II endometrial carcinoma

由 Shukla, Gaurav, Beriwal, Sushil, Krivak, Thomas C., Kelley, Joseph L., Sukumvanich, Paniti, Edwards, Robert P., Richard, Scott, Olawaiye, Alexander, Zorn, Kristin K.
發表在 J Contemp Brachytherapy (2011)

Does Aggressive Surgery Improve Outcomes? Interaction Between Preoperative Disease Burden and Complex Surgery in Patients With Advanced-Stage Ovarian Cancer: An Analysis of GOG 182

由 Horowitz, Neil S., Miller, Austin, Rungruang, Bunja, Richard, Scott D., Rodriguez, Noah, Bookman, Michael A., Hamilton, Chad A., Krivak, Thomas C., Maxwell, G. Larry
發表在 J Clin Oncol (2015)

Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group St...

由 Tian, Chunqiao Q., Darcy, Kathleen M., Krivak, Thomas C., DeLoia, Julie A., Armstrong, Deborah, Davis, Warren, Zhao, Hua, Moysich, Kirsten, Ambrosone, Christine B.
出版 2013

Differential Analysis of Ovarian and Endometrial Cancers Identifies a Methylator Phenotype

由 Kolbe, Diana L., DeLoia, Julie A., Porter-Gill, Patricia, Strange, Mary, Petrykowska, Hanna M., Guirguis, Alfred, Krivak, Thomas C., Brody, Lawrence C., Elnitski, Laura
出版 2012

The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: A Gynecologic Oncology Group study(, )

由 Fader, Amanda Nickles, Java, James, Krivak, Thomas C., Bristow, Robert E., Tergas, Ana I., Bookman, Michael A., Armstrong, Deborah K., Tanner, Edward J., Gershenson, David M.
發表在 Gynecol Oncol (2013)

Proteomic Analysis of Matched Formalin-Fixed, Paraffin-Embedded Specimens in Patients with Advanced Serous Ovarian Carcinoma

由 Smith, Ashlee L., Sun, Mai, Bhargava, Rohit, Stewart, Nicolas A., Flint, Melanie S., Bigbee, William L., Krivak, Thomas C., Strange, Mary A., Cooper, Kristine L., Zorn, Kristin K.
發表在 Proteomes (2013)

Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecolo...

由 Tian, Chunqiao, Ambrosone, Christine B, Darcy, Kathleen M, Krivak, Thomas C, Armstrong, Deborah K., Bookman, Michael A, Davis, Warren, Zhao, Hua, Moysich, Kirsten, Gallion, Holly, DeLoia, Julie A
出版 2011

Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidity

由 Laskey, Robin A, Richard, Scott D, Smith, Ashlee L, Lin, Jeff F, Beck, Tiffany L, Lesnock, Jamie L, Kelley, Joseph L, Olawaiye, Alexander B, Sukumvanich, Paniti, Krivak, Thomas C
出版 2014

The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: A gynecologic oncology group study (,,)

由 Hamilton, Chad A., Miller, Austin, Miller, Caela, Krivak, Thomas C., Farley, John H., Chernofsky, Mildred R., Stany, Michael P., Rose, G. Scott, Markman, Maurie, Ozols, Robert F., Armstrong, Deborah K., Maxwell, G. Larry
出版 2011